Free Trial

Docebo (DCBO) Financials

Docebo logo
$29.62 -0.16 (-0.54%)
As of 04/14/2025 04:00 PM Eastern
Annual Income Statements for Docebo

Annual Income Statements for Docebo

This table shows Docebo's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024
Net Income / (Loss) Attributable to Common Shareholders
-11 -7.12 -13 -4.67 6.47 23
Consolidated Net Income / (Loss)
-12 -8.02 -14 7.02 2.84 27
Net Income / (Loss) Continuing Operations
-12 -8.02 -14 6.93 3.02 27
Total Pre-Tax Income
-11 -7.68 -13 7.78 4.85 24
Total Operating Income
-9.81 -7.63 -13 4.19 -3.71 21
Total Gross Profit
33 51 83 115 146 176
Total Revenue
41 63 104 143 181 217
Operating Revenue
41 63 104 143 181 217
Total Cost of Revenue
8.37 12 21 28 34 41
Operating Cost of Revenue
8.37 12 21 28 34 41
Total Operating Expenses
43 59 97 111 150 154
Selling, General & Admin Expense
14 19 31 35 40 40
Marketing Expense
18 24 43 60 67 70
Research & Development Expense
9.44 13 20 25 35 44
Depreciation Expense
0.69 1.21 2.02 2.33 3.14 3.38
Other Special Charges / (Income)
0.92 1.78 0.47 -11 4.39 -2.39
Total Other Income / (Expense), net
-1.50 -0.05 0.02 3.51 8.74 2.40
Interest Expense
0.80 0.13 0.07 -3.51 -8.74 -2.40
Income Tax Expense
0.61 0.34 0.17 0.76 2.01 -3.02
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)
-0.54 -0.89 -0.41 12 -3.63 3.33
Basic Earnings per Share
- ($0.28) ($0.41) $0.21 $0.09 $0.88
Weighted Average Basic Shares Outstanding
24.36M 28.93M 32.87M 33.07M 32.53M 30.27M
Diluted Earnings per Share
($0.49) ($0.28) ($0.41) $0.21 $0.08 $0.86
Weighted Average Diluted Shares Outstanding
24.36M 28.93M 32.87M 34.04M 33.68M 30.99M
Weighted Average Basic & Diluted Shares Outstanding
24.36M 32.63M 32.86M 32.91M 30.31M 30.26M

Quarterly Income Statements for Docebo

No quarterly income statements for Docebo are available.


Annual Cash Flow Statements for Docebo

This table details how cash moves in and out of Docebo's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024
Net Change in Cash & Equivalents
42 174 -3.98 13 -145 32
Net Cash From Operating Activities
-4.58 4.79 -3.31 13 29 32
Net Cash From Continuing Operating Activities
-3.56 5.73 -3.31 13 29 32
Net Income / (Loss) Continuing Operations
-12 -8.02 -14 7.02 12 27
Consolidated Net Income / (Loss)
-12 -8.02 -14 7.02 12 27
Depreciation Expense
0.69 1.21 2.02 2.33 3.14 3.38
Non-Cash Adjustments To Reconcile Net Income
3.15 4.75 -4.02 -8.86 0.65 -5.61
Changes in Operating Assets and Liabilities, net
4.51 7.79 12 13 14 7.14
Net Cash From Investing Activities
-0.37 -3.53 -1.15 0.00 -0.64 0.00
Net Cash From Continuing Investing Activities
-0.37 -3.53 -1.15 0.00 -0.64 0.00
Net Cash From Financing Activities
47 172 -0.02 0.00 -159 0.00
Net Cash From Continuing Financing Activities
47 172 -0.02 0.00 -159 0.00
Cash Interest Received
- - 0.40 2.11 7.95 2.47

Quarterly Cash Flow Statements for Docebo

No quarterly cash flow statements for Docebo are available.


Annual Balance Sheets for Docebo

This table presents Docebo's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024
Total Assets
64 254 268 284 158 191
Total Current Assets
59 240 252 264 127 154
Cash & Equivalents
46 220 215 216 72 93
Note & Lease Receivable
0.70 1.44 0.10 2.95 0.08 0.04
Accounts Receivable
10 16 28 38 42 46
Prepaid Expenses
1.86 2.94 6.99 6.38 5.99 8.60
Current Deferred & Refundable Income Taxes
- - 0.10 0.44 0.96 0.04
Other Current Assets
- - 1.39 - 6.39 7.45
Plant, Property, & Equipment, net
1.48 2.29 2.65 2.62 2.11 2.00
Plant, Property & Equipment, gross
1.48 2.29 2.65 2.62 2.11 2.00
Total Noncurrent Assets
3.12 12 14 17 29 34
Goodwill
0.00 5.60 5.30 5.98 14 14
Intangible Assets
0.00 2.10 1.58 1.15 2.40 1.67
Noncurrent Deferred & Refundable Income Taxes
- - 0.00 0.12 0.33 5.21
Other Noncurrent Operating Assets
3.12 4.25 6.91 9.97 12 14
Total Liabilities & Shareholders' Equity
64 254 268 284 158 191
Total Liabilities
32 54 78 91 108 133
Total Current Liabilities
29 46 69 84 101 129
Accounts Payable
9.59 16 23 26 32 35
Current Deferred & Payable Income Tax Liabilities
- - 0.07 0.10 0.25 0.34
Other Current Liabilities
19 30 46 57 69 74
Total Noncurrent Liabilities
3.94 5.58 6.06 7.00 5.96 4.35
Capital Lease Obligations
2.48 2.54 2.69 1.69 0.64 0.15
Noncurrent Deferred & Payable Income Tax Liabilities
0.00 0.71 0.69 1.28 1.42 0.03
Noncurrent Employee Benefit Liabilities
1.44 2.33 2.56 2.42 3.29 3.37
Other Noncurrent Operating Liabilities
- 0.00 0.12 1.08 0.62 0.79
Total Equity & Noncontrolling Interests
31 200 191 192 51 58
Total Preferred & Common Equity
31 200 191 192 51 58
Total Common Equity
31 200 191 192 51 58
Common Stock
91 267 270 277 261 272
Retained Earnings
-60 -68 -82 -75 -205 -205
Accumulated Other Comprehensive Income / (Loss)
0.81 1.70 2.11 -9.57 -5.95 -9.28

Quarterly Balance Sheets for Docebo

No quarterly balance sheets for Docebo are available.


Annual Metrics and Ratios for Docebo

This table displays calculated financial ratios and metrics derived from Docebo's official financial filings.

Metric 2019 2020 2021 2022 2023 2024
Growth Metrics
- - - - - -
Revenue Growth
0.00% 51.82% 65.68% 37.10% 26.54% 19.96%
EBITDA Growth
0.00% 35.40% -78.92% 157.45% -108.73% 4,436.73%
EBIT Growth
0.00% 28.16% -77.01% 131.32% -188.65% 673.91%
NOPAT Growth
0.00% 22.24% -76.33% 140.09% -157.61% 1,204.12%
Net Income Growth
0.00% 32.72% -69.67% 151.60% -59.53% 841.41%
EPS Growth
0.00% 42.86% -46.43% 151.22% -61.90% 975.00%
Operating Cash Flow Growth
0.00% 204.56% -169.07% 498.73% 121.50% 8.30%
Free Cash Flow Firm Growth
0.00% 0.00% -20.97% 231.60% -170.23% 592.95%
Invested Capital Growth
0.00% -13.59% -34.95% -10.14% 8.69% 20.93%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics
- - - - - -
Gross Margin
79.82% 81.66% 80.06% 80.28% 80.92% 80.96%
EBITDA Margin
-23.69% -10.08% -10.88% 4.56% -0.31% 11.38%
Operating Margin
-23.67% -12.12% -12.90% 2.93% -2.05% 9.82%
EBIT Margin
-25.36% -12.00% -12.82% 2.93% -2.05% 9.82%
Profit (Net Income) Margin
-28.75% -12.74% -13.05% 4.91% 1.57% 12.32%
Tax Burden Percent
105.39% 104.38% 101.28% 90.18% 58.61% 112.75%
Interest Burden Percent
107.57% 101.72% 100.49% 185.95% -130.62% 111.37%
Effective Tax Rate
0.00% 0.00% 0.00% 9.82% 41.40% -12.75%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)
-37.97% -6.92% -6.96% 3.67% 2.34% 49.29%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)
-16.46% -4.75% -5.12% 1.52% -1.68% 12.20%
Return on Assets (ROA)
-18.66% -5.04% -5.21% 2.54% 1.28% 15.32%
Return on Common Equity (ROCE)
-37.97% -6.92% -6.96% 3.67% 2.34% 49.29%
Return on Equity Simple (ROE_SIMPLE)
-37.97% -4.00% -7.13% 3.65% 5.60% 46.29%
Net Operating Profit after Tax (NOPAT)
-6.87 -5.34 -9.41 3.77 -2.17 24
NOPAT Margin
-16.57% -8.49% -9.03% 2.64% -1.20% 11.07%
Net Nonoperating Expense Percent (NNEP)
-11.45% -2.07% -1.97% 1.53% 3.53% 3.80%
Return On Investment Capital (ROIC_SIMPLE)
- - - - -4.23% 41.45%
Cost of Revenue to Revenue
20.18% 18.34% 19.94% 19.72% 19.08% 19.04%
SG&A Expenses to Revenue
33.30% 29.59% 29.45% 24.42% 22.03% 18.40%
R&D to Revenue
22.77% 21.27% 19.53% 17.34% 19.62% 20.24%
Operating Expenses to Revenue
103.48% 93.78% 92.96% 77.35% 82.97% 71.15%
Earnings before Interest and Taxes (EBIT)
-11 -7.55 -13 4.19 -3.71 21
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-9.82 -6.34 -11 6.52 -0.57 25
Valuation Ratios
- - - - - -
Price to Book Value (P/BV)
0.00 0.00 11.53 5.67 31.39 23.49
Price to Tangible Book Value (P/TBV)
0.00 0.00 11.96 5.88 46.74 32.12
Price to Revenue (P/Rev)
0.00 0.00 21.09 7.62 8.81 6.25
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 246.31 57.96
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.41% 1.73%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 19.05 6.12 8.41 5.83
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 134.13 0.00 51.24
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 208.91 0.00 59.38
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 231.65 0.00 52.67
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 66.26 52.05 39.95
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 152.04 0.00 63.52
Leverage & Solvency
- - - - - -
Debt to Equity
0.08 0.01 0.01 0.01 0.01 0.00
Long-Term Debt to Equity
0.08 0.01 0.01 0.01 0.01 0.00
Financial Leverage
-1.40 -1.12 -1.09 -1.11 -1.17 -1.32
Leverage Ratio
2.04 1.37 1.34 1.44 1.82 3.22
Compound Leverage Factor
2.19 1.40 1.34 2.68 -2.38 3.58
Debt to Total Capital
7.42% 1.26% 1.39% 0.87% 1.24% 0.27%
Short-Term Debt to Total Capital
0.06% 0.01% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
7.36% 1.25% 1.39% 0.87% 1.24% 0.27%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
92.58% 98.74% 98.61% 99.13% 98.76% 99.73%
Debt to EBITDA
-0.26 -0.40 -0.24 0.26 -1.12 0.01
Net Debt to EBITDA
4.46 34.24 18.74 -32.92 125.33 -3.74
Long-Term Debt to EBITDA
-0.25 -0.40 -0.24 0.26 -1.12 0.01
Debt to NOPAT
-0.37 -0.48 -0.29 0.45 -0.29 0.01
Net Debt to NOPAT
6.37 40.66 22.59 -56.86 32.80 -3.85
Long-Term Debt to NOPAT
-0.36 -0.48 -0.29 0.45 -0.29 0.01
Altman Z-Score
0.00 0.00 17.61 8.08 8.33 6.28
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - -
Current Ratio
2.07 5.24 3.63 3.12 1.26 1.20
Quick Ratio
2.00 5.18 3.51 3.04 1.13 1.07
Cash Flow Metrics
- - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -3.61 -4.37 5.75 -4.04 20
Operating Cash Flow to CapEx
-1,251.91% 443.20% -289.00% 0.00% 4,602.36% 0.00%
Free Cash Flow to Firm to Interest Expense
0.00 -27.78 -67.22 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
-5.76 36.85 -50.91 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
-6.22 28.54 -68.52 0.00 0.00 0.00
Efficiency Ratios
- - - - - -
Asset Turnover
0.65 0.40 0.40 0.52 0.82 1.24
Accounts Receivable Turnover
4.10 4.88 4.81 4.38 4.56 4.97
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
28.06 33.40 42.25 54.25 76.43 105.54
Accounts Payable Turnover
0.87 0.90 1.07 1.15 1.20 1.24
Days Sales Outstanding (DSO)
89.02 74.83 75.94 83.28 80.03 73.48
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
418.41 406.63 342.17 316.55 305.18 294.00
Cash Conversion Cycle (CCC)
-329.38 -331.80 -266.23 -233.28 -225.15 -220.52
Capital & Investment Metrics
- - - - - -
Invested Capital
-13 -14 -19 -21 -20 -15
Invested Capital Turnover
-3.26 -4.64 -6.15 -6.98 -8.81 -12.37
Increase / (Decrease) in Invested Capital
0.00 -1.73 -5.05 -1.98 1.86 4.10
Enterprise Value (EV)
0.00 0.00 1,985 874 1,521 1,264
Market Capitalization
0.00 0.00 2,198 1,089 1,592 1,357
Book Value per Share
$1.29 $6.92 $5.84 $5.85 $1.54 $1.91
Tangible Book Value per Share
$1.29 $6.66 $5.63 $5.63 $1.04 $1.39
Total Capital
34 203 193 194 51 58
Total Debt
2.52 2.56 2.69 1.69 0.64 0.15
Total Long-Term Debt
2.50 2.54 2.69 1.69 0.64 0.15
Net Debt
-44 -217 -213 -215 -71 -92
Capital Expenditures (CapEx)
0.37 1.08 1.15 0.00 0.64 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-16 -26 -33 -37 -45 -67
Debt-free Net Working Capital (DFNWC)
30 194 182 179 27 26
Net Working Capital (NWC)
30 194 182 179 27 26
Net Nonoperating Expense (NNE)
5.05 2.68 4.19 -3.24 -5.01 -2.73
Net Nonoperating Obligations (NNO)
-44 -215 -210 -214 -70 -73
Total Depreciation and Amortization (D&A)
0.69 1.21 2.02 2.33 3.14 3.38
Debt-free, Cash-free Net Working Capital to Revenue
-38.26% -40.75% -31.66% -25.94% -25.13% -30.84%
Debt-free Net Working Capital to Revenue
73.40% 308.38% 174.90% 125.41% 14.65% 11.82%
Net Working Capital to Revenue
73.35% 308.35% 174.90% 125.41% 14.65% 11.82%
Earnings Adjustments
- - - - - -
Adjusted Basic Earnings per Share
$0.00 ($0.26) ($0.41) $0.21 $0.09 $0.88
Adjusted Weighted Average Basic Shares Outstanding
0.00 28.93M 32.87M 33.07M 32.53M 30.27M
Adjusted Diluted Earnings per Share
$0.00 ($0.26) ($0.41) $0.21 $0.08 $0.86
Adjusted Weighted Average Diluted Shares Outstanding
0.00 28.93M 32.87M 34.04M 33.68M 30.99M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 32.63M 32.86M 32.91M 30.31M 30.26M
Normalized Net Operating Profit after Tax (NOPAT)
-6.22 -4.10 -9.08 -6.25 0.40 13
Normalized NOPAT Margin
-15.01% -6.51% -8.71% -4.37% 0.22% 6.10%
Pre Tax Income Margin
-27.28% -12.21% -12.88% 5.45% 2.68% 10.93%
Debt Service Ratios
- - - - - -
EBIT to Interest Expense
-13.20 -58.08 -205.60 0.00 0.00 0.00
NOPAT to Interest Expense
-8.63 -41.07 -144.84 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
-13.66 -66.39 -223.22 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
-9.09 -49.38 -162.45 0.00 0.00 0.00
Payout Ratios
- - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
-32.29% -144.80% 0.00% 0.00% 5,614.37% 0.00%

Quarterly Metrics and Ratios for Docebo

No quarterly metrics and ratios for Docebo are available.


Frequently Asked Questions About Docebo's Financials

When does Docebo's fiscal year end?

According to the most recent income statement we have on file, Docebo's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Docebo's net income changed over the last 5 years?

Docebo's net income appears to be on an upward trend, with a most recent value of $26.74 million in 2024, falling from -$11.91 million in 2019. The previous period was $2.84 million in 2023.

What is Docebo's operating income?
Docebo's total operating income in 2024 was $21.29 million, based on the following breakdown:
  • Total Gross Profit: $175.64 million
  • Total Operating Expenses: $154.34 million
How has Docebo revenue changed over the last 5 years?

Over the last 5 years, Docebo's total revenue changed from $41.44 million in 2019 to $216.93 million in 2024, a change of 423.4%.

How much debt does Docebo have?

Docebo's total liabilities were at $132.95 million at the end of 2024, a 23.5% increase from 2023, and a 309.3% increase since 2019.

How much cash does Docebo have?

In the past 5 years, Docebo's cash and equivalents has ranged from $46.28 million in 2019 to $219.66 million in 2020, and is currently $92.54 million as of their latest financial filing in 2024.

How has Docebo's book value per share changed over the last 5 years?

Over the last 5 years, Docebo's book value per share changed from 1.29 in 2019 to 1.91 in 2024, a change of 48.0%.

Remove Ads


This page (NASDAQ:DCBO) was last updated on 4/15/2025 by MarketBeat.com Staff
From Our Partners